Private Equity Archives - Pagina 5 van 6 - Gilde Healthcare

Menu
Menu
Home

Nieuws

Nieuws

Nieuws
Venture&Growth

Nieuws
Private Equity

Gilde Healthcare announces successful sale of health-it software company Performation to Enovation, part of Legrand

Exit confirms Gilde Healthcare's investment strategy of building market-leading healthcare companies that deliver better care at lower cost Under ownership of Gilde Healthcare’s private equity fund, Performation has evolved into...

13 februari 2025

Gilde Healthcare company SynOx Therapeutics announces Board Chair transition to align with advancing Regulatory and Commercialization Strategy

SynOx Therapeutics Limited (“SynOx”), a late-stage clinical biopharmaceutical company developing of emactuzumab for Tenosynovial Giant Cell Tumours (TGCT), today announced the execution of a planned and orderly transition of its...

1 april 2025

Gilde Healthcare announces successful sale of health-it software company Performation to Enovation, part of Legrand

Exit confirms Gilde Healthcare's investment strategy of building market-leading healthcare companies that deliver better care at lower cost Under ownership of Gilde Healthcare’s private equity fund, Performation has evolved into...

13 februari 2025

Gilde Healthcare company SynOx Therapeutics announces Board Chair transition to align with advancing Regulatory and Commercialization Strategy

SynOx Therapeutics Limited (“SynOx”), a late-stage clinical biopharmaceutical company developing of emactuzumab for Tenosynovial Giant Cell Tumours (TGCT), today announced the execution of a planned and orderly transition of its...

1 april 2025

Filter & zoek

Fonds strategie:
  • All
  • Private Equity
  • Venture&Growth
Zoek:

Gilde Healthcare announces successful sale of health-it software company Performation to E...

Exit confirms Gilde Healthcare’s investment strategy of building market-leading healthcare companies that deliver better care at lower cost Under ownership of Gilde Healthcare’s private equity fund, Performation has evolved into a leading European SaaS healthcare platform through seven strategic acquisitions and product innovations Revenue more than doubled...
13 februari 2025

Gilde Healthcare company NIZO participates in national consortium investing in precision f...

The Netherlands is strengthening its position as a global leader in cellular agriculture with the launch of two independent, open-access scale-up facilities. These facilities, developed in a collaboration between NIZO Food Research, Cultivate at Scale (CaS), Cellular Agriculture Netherlands Foundation (CAN), Biotechnology Fermentation Factory Ede (BFF), Mosa...
4 februari 2025

Gilde Healthcare invests alongside Capital A in Tromp Medical to accelerate international ...

Tromp Medical, Europe’s largest independent medical imaging sales and service organization, has attracted Gilde Healthcare as new investor to drive further growth in the medical imaging market. Headquartered in the Netherlands, Tromp Medical specializes in installing and maintaining various medical imaging equipment modalities such as mammography, CT,...
16 december 2024

GILDE HEALTHCARE COMPANY SYNEXA LIFE SCIENCES ACQUIRES ALDERLEY ANALYTICAL TO EXPAND BIOAN...

Synexa Life Sciences, a specialist biomarker and bioanalysis service provider, announces the acquisition of Alderley Analytical Ltd, based in Manchester, UK. The transaction marks an important milestone in Synexa’s ‘buy and build’ growth strategy, underpinning the company’s vision to be ‘the scientific partner of choice for biomarker...
3 oktober 2024

Gilde Healthcare portfolio company Eetgemak joins forces with TotaalVERS to become the lea...

Combining TotaalVERS and Eetgemak will form a leading end-to-end foodservice provider*, offering a wide range of convenience meals, ingredients and groceries to the healthcare sector. The partnership emphasizes commitment to quality, service, and innovation in the healthcare market. Strengthening their joint position will further elevate service levels...
5 juli 2024

Gilde Healthcare sells RAD-x to a consortium of Swiss Life Asset Managers and Vesper Infra...

Gilde Healthcare’s Private Equity Fund (“Gilde Healthcare”), a specialized healthcare investor, has reached a binding agreement to sell its majority stake in RAD-x to a consortium of Swiss Life Asset Managers and Vesper Next Generation Infrastructure Fund I. Gilde Healthcare invested in and, together with the founders,...
18 maart 2024

Gilde Healthcare company NIZO acquires lactic acid facility and strengthens partnership wi...

NIZO food research B.V. (“NIZO”) is proud to announce the signature of a long-term contract manufacturing partnership with dsm-firmenich. This strategic alliance encompasses the acquisition of the neighboring lactic acid facility from Vika Nutrition B.V., a Givaudan group company. With this move, NIZO widens its capabilities and...
29 februari 2024

Gilde Healthcare portfolio company Scharenborg Group appoints Johannes Schneider Littfeld ...

The Scharenborg Group, a leading footcare technology firm has appointed Johannes Schneider Littfeld as Chairman to the Advisory Board. Johannes is an experienced executive in the MedTech- and patient care industry. He spent 15 years in senior management of Otto Bock, the global leader in Orthopedic Technology....
8 februari 2024

Gilde Healthcare invests in German precision surgical instruments contract manufacturer Ko...

The acquisition of Koscher & Würtz represents a major step for Gilde Healthcare in forming a market leading instrument contract manufacturing group, following its initial investment in Chr. Diener, less than 18 months ago. Koscher & Würtz (K&W) will join as a group company next to Chr....
20 november 2023
Loading...
Dit waren alle artikelen
3ce7c7c4c9